GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnGes Inc (STU:AJW) » Definitions » Insider Ownership

AnGes (STU:AJW) Insider Ownership : 0.00 % (As of Dec. 13, 2024)


View and export this data going back to 2019. Start your Free Trial

What is AnGes Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, AnGes's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, AnGes's Institutional Ownership is 1.16%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, AnGes's Float Percentage Of Total Shares Outstanding is 0.00%.


AnGes Insider Ownership Historical Data

The historical data trend for AnGes's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnGes Insider Ownership Chart

AnGes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Insider Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AnGes Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AnGes Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


AnGes Business Description

Traded in Other Exchanges
Address
7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.

AnGes Headlines

No Headlines